Luteinizing hormone-releasing hormone (LHRH) neurons were immunohistochemically studied in rats of both sexes at peripubertal ages. The number of immunoreactive LHRH neurons (irLHRH neurons) was counted in the brain region from the level of the septum-preoptic area to the level of the rostral part o
Effect of luteinizing hormone releasing hormone (LHRH) agonists on body weight in rats
β Scribed by Dr. Khalid Ataya; Alan Weintraub; Joseph Dunbar; Stephen Zimniski; David Puett; William Lemaire
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 755 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A 2 Γ 2 factorial design was performed to determine the effect of a permeation enhancer (oleic acid/propylene glycol), iontophoresis (2 V), and the combination of the two treatments on the permeation enhancement of a model peptide, LHRH (luteinizing hormone releasing hormone), through human epiderma
The synthesis of new photolabeling analogues of luteinizing hormone releasing hormone is described. Peptides were prepared by the solid-phasc method, and the photolabeling moiety was introduced as the 4'-nitrophenylalanine precursor. This amino acid, either of the L or u configuration, was placed at
## Background: Luteinizing hormone-releasing hormone agonists (lhrh-a) have become an established treatment for certain patients with prostate carcinoma. lhrh-a are known to decrease bone mineral density. the purpose of this study was to determine the risk of bone fracture in men receiving lhrh-a f
Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for